Position in GILD
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$3,973,393
-$507,352 QoQ
Shares Held
31,450
-2.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
1.10%
of 13F equity value
Holder Rank
#635
of 2,265 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in GILD Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MERIDIAN INVESTMENT COUNSEL INC. holds $23,634,584 across 8 Drug Manufacturers - General names. GILD ranks #3 (16.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
25,506 | $6,418,329 | |
| 2 | JNJ |
Johnson & Johnson
|
22,704 | $5,766,134 | |
| 3 | GILD |
Gilead Sciences, Inc.
This page
|
31,450 | $3,973,393 | |
| 4 | NVO |
Novo Nordisk A S
|
63,091 | $3,024,582 | |
| 5 | AMGN |
Amgen Inc
|
6,995 | $2,533,029 | |
| 6 | PFE |
Pfizer Inc
|
50,187 | $1,208,502 | |
| 7 | MRK |
Merck & Co., Inc.
|
3,923 | $504,105 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
3,584 | $206,510 |
All Filings in GILD
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,973,393 | 31,450 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $4,480,745 | 32,150 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $3,942,408 | 32,120 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $2,349,537 | 21,167 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $2,346,785 | 21,167 | Shares | Sole | 2025-07-16 | |
| 2025-03-31 | $2,371,762 | 21,167 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $1,973,669 | 21,367 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,808,596 | 21,572 | Shares | Sole | 2024-11-06 | |
| 2024-06-30 | $1,624,135 | 23,672 | Shares | Sole | 2024-07-19 | |
| 2024-03-31 | $1,747,891 | 23,862 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $1,949,019 | 24,059 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $1,829,210 | 24,409 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $1,942,857 | 25,209 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $2,091,590 | 25,209 | Shares | Sole | 2023-05-05 | |
| 2022-12-31 | $2,181,362 | 25,409 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $1,606,037 | 26,034 | Shares | Sole | 2022-11-08 | |
| 2022-06-30 | $1,616,887 | 26,159 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $1,623,044 | 27,301 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $1,982,325 | 27,301 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $1,926,183 | 27,576 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $1,936,756 | 28,126 | Shares | Sole | 2021-07-23 | |
| 2021-03-31 | $1,811,643 | 28,031 | Shares | Sole | 2021-05-03 | |
| 2020-12-31 | $1,638,912 | 28,131 | Shares | Sole | 2021-02-03 | |
| 2020-09-30 | $1,812,352 | 28,681 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $2,214,410 | 28,781 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $2,136,341 | 28,576 | Shares | Sole | 2020-04-30 | |
| No filing history on record for this holder in this stock. | ||||||